HIGH
CVE-2015-6495
CWE-200Published: November 26, 2019· Updated: Jun 17, 2026
7.5
CVSS v3.1
Official Description
There is Sensitive Information in Cloudera Manager before 5.4.6 Diagnostic Support Bundles.
Technical Analysis
CVE-2015-6495 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
A successful exploit results in complete confidentiality breach (data exposure), with a CVSS base score of 7.5.
From a weakness classification perspective (CWE-200): Information exposure vulnerabilities leak sensitive data to unauthorized actors.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Affected Vendors & Products
cloudera1 product(s)
cloudera manager
Source: NVD CPE · 1 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (2)
→
Quick Facts
CVE IDCVE-2015-6495
CVSS Score7.5 / 10
SeverityHIGH
WeaknessCWE-200
CISA KEVNo
Affected1 vendor(s)
PublishedNov 26, 2019
Related CVEs (CWE-200)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2015-6495 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.